RX South LLC DBA RX3 Pharmacy

FDA Regulatory Profile

RX South LLC DBA RX3 Pharmacy appears in FDA public data with 2 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1164-2014, Class II) was initiated on January 28, 2014.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1164-2014Class IIHydroxyprogesterone Caproate 250mg/ml in Sesame Oil, 1 ml injectable solution, in 3 ml single dose sJanuary 28, 2014
D-191-2013Class IIMedi-bolic Booster Injectable (methionine 8.3 mg/mL, choline chloride 16.6 mg/mL, inositol 16.6 mg/mJanuary 22, 2013